Are routine breast and pelvic examinations necessary for women starting combined oral contraception?
Millions of women worldwide use combined oral contraception (COC). Most of them are in good health and have no contraindications to using any contraceptive method. Although extremely safe for the vast majority of women and even though the absolute risk of complications is very small, COC is associated with an increased relative risk of serious conditions including cardiovascular disease and breast and cervical cancer. In many countries, breast and pelvic examinations are routinely undertaken annually for all women using hormonal contraception. Breast and pelvic examination have low detection rates for abnormality and may yield clinically irrelevant results, causing anxiety and inconvenience to the patient for no obvious gain. There is no good evidence to support routine breast or pelvic examination either for women starting hormonal contraception or for monitoring long-term use.
Scott
A
A
Lothian Health Family Planning and Well Woman Services, 18 Dean Terrace, Edinburgh EH4 1NL. ascott@doctors.org.uk
Glasier
A F
AF
D001940:Breast; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000453:epidemiology; D003277:Contraceptives, Oral, Combined / Q000627:therapeutic use*; D003955:Diagnostic Tests, Routine; D005260:Female; D006801:Humans; D010388:Pelvis; D012307:Risk Factors; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000453:epidemiology
D003277:Contraceptives, Oral, Combined